class name | count |
---|---|
rosids | 4 |
class name | count |
---|---|
Rutaceae | 4 |
br08003 Category | # of metabolite |
---|---|
Imidazole alkaloids | 2 |
br08003 Category | KEGG ID | KNApSAcK ID |
---|---|---|
Imidazole alkaloids | C07474 | C00002355 |
Imidazole alkaloids | C10610 | C00002356 |
KCF-S ID | # of metabolite |
---|---|
No. 7873 | 1 |
No. 8181 | 1 |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
figure |
---|---|---|---|---|---|---|---|
C00002355
![]() |
Pilocarpine
|
CHEMBL550
CHEMBL91776 CHEMBL611494 CHEMBL1622903 |
D010862
|
28 / 30 / 56 | 9 / 74 | No. 7873 |
![]() |
C00002356
![]() |
Pilosine
|
CHEMBL524663
CHEMBL1974385 |
No. 8181 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00002355 | 1 / 0 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | C00002355 | 7 / 37 |
Q99700 | Ataxin-2 | Unclassified protein | C00002355 | 1 / 1 |
P49798 | Regulator of G-protein signaling 4 | Unclassified protein | C00002355 | 2 / 0 |
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00002355 | 0 / 0 |
O15245 | Solute carrier family 22 member 1 | Drug uniporter | C00002355 | 0 / 0 |
O75604 | Ubiquitin carboxyl-terminal hydrolase 2 | Enzyme | C00002355 | 0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | C00002355 | 11 / 10 |
P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00002355 | 0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00002355 | 0 / 1 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00002355 | 0 / 0 |
Q92830 | Histone acetyltransferase KAT2A | Enzyme | C00002355 | 0 / 0 |
P25101 | Endothelin-1 receptor | Endothelin receptor | C00002355 | 0 / 0 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00002355 | 0 / 0 |
P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00002355 | 2 / 0 |
P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00002355 | 0 / 0 |
P18054 | Arachidonate 12-lipoxygenase, 12S-type | Enzyme | C00002355 | 2 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00002355 | 0 / 0 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00002355 | 0 / 0 |
P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | C00002355 | 0 / 0 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00002355 | 0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00002355 | 1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00002355 | 0 / 1 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00002355 | 0 / 0 |
O00255 | Menin | Unclassified protein | C00002355 | 2 / 5 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00002355 | 1 / 2 |
P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00002355 | 1 / 0 |
P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00002355 | 0 / 0 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00002355
|
1128 | CHRM1, HM1, M1, M1R | cholinergic receptor, muscarinic 1 |
C00002355
|
1129 | CHRM2, HM2 | cholinergic receptor, muscarinic 2 |
C00002355
|
1131 | CHRM3, EGBRS, HM3 | cholinergic receptor, muscarinic 3 |
C00002355
|
1132 | CHRM4, HM4, M4R | cholinergic receptor, muscarinic 4 |
C00002355
|
1548 | CYP2A6, CPA6, CYP2A, CYP2A3, CYPIIA6, P450C2A, P450PB | cytochrome P450, family 2, subfamily A, polypeptide 6 (EC:1.14.14.1) |
C00002355
|
3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00002355
|
5599 | MAPK8, JNK, JNK-46, JNK1, JNK1A2, JNK21B1/2, PRKM8, SAPK1, SAPK1c | mitogen-activated protein kinase 8 (EC:2.7.11.24) |
C00002355
|
5747 | PTK2, FADK, FAK, FAK1, FRNK, PPP1R71, p125FAK, pp125FAK | protein tyrosine kinase 2 (EC:2.7.10.2) |
C00002355
|
OMIM | preferred title | UniProt |
---|---|---|
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#103780 | Alcohol dependence |
P08172
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#114500 | Colorectal cancer; crc |
P18054
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#133239 | Esophageal cancer |
P04637
P18054 |
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#211980 | Lung cancer |
P04637
|
#608516 | Major depressive disorder; mdd |
P08172
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#604906 | Schizophrenia 9; sczd9 |
P49798
|
#181500 | Schizophrenia; sczd |
P49798
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
|
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00016 | Oral cancer |
P04637
(related)
P04637 (marker) |
H00017 | Esophageal cancer |
P04637
(related)
P04637 (marker) |
H00018 | Gastric cancer |
P04637
(related)
|
H00019 | Pancreatic cancer |
P04637
(related)
P04637 (marker) |
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00022 | Bladder cancer |
P04637
(related)
|
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) |
H00026 | Endometrial Cancer |
P04637
(related)
|
H00027 | Ovarian cancer |
P04637
(related)
|
H00028 | Choriocarcinoma |
P04637
(related)
|
H00029 | Vulvar cancer |
P04637
(related)
|
H00031 | Breast cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
|
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
|
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00042 | Glioma |
P04637
(related)
P04637 (marker) |
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00046 | Cholangiocarcinoma |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00055 | Laryngeal cancer |
P04637
(related)
P04637 (marker) |
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00021 | Renal cell carcinoma |
P04637
(marker)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q03164
(related)
Q03164 (marker) |
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q99700
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D000138 | Acidosis |
C00002355
|
D001145 | Arrhythmias, Cardiac |
C00002355
|
D054537 | Atrioventricular Block |
C00002355
|
D001308 | Auditory Perceptual Disorders |
C00002355
|
D001480 | Basal Ganglia Diseases |
C00002355
|
D001764 | Blepharospasm |
C00002355
|
D001919 | Bradycardia |
C00002355
|
D001925 | Brain Damage, Chronic |
C00002355
|
D001929 | Brain Edema |
C00002355
|
D001930 | Brain Injuries |
C00002355
|
D002545 | Brain Ischemia |
C00002355
|
D006332 | Cardiomegaly |
C00002355
|
D002375 | Catalepsy |
C00002355
|
D002544 | Cerebral Infarction |
C00002355
|
D019970 | Cocaine-Related Disorders |
C00002355
|
D003072 | Cognition Disorders |
C00002355
|
D003221 | Confusion |
C00002355
|
D003229 | Conjunctival Diseases |
C00002355
|
D003693 | Delirium |
C00002355
|
D003704 | Dementia |
C00002355
|
D003711 | Demyelinating Diseases |
C00002355
|
D004195 | Disease Models, Animal |
C00002355
|
D004244 | Dizziness |
C00002355
|
D004828 | Epilepsies, Partial |
C00002355
|
D004827 | Epilepsy |
C00002355
|
D004832 | Epilepsy, Absence |
C00002355
|
D004833 | Epilepsy, Temporal Lobe |
C00002355
|
D004830 | Epilepsy, Tonic-Clonic |
C00002355
|
D017889 | Exfoliation Syndrome |
C00002355
|
D005221 | Fatigue |
C00002355
|
D005334 | Fever |
C00002355
|
D005901 | Glaucoma |
C00002355
|
D015812 | Glaucoma, Angle-Closure |
C00002355
|
D005902 | Glaucoma, Open-Angle |
C00002355
|
D005911 | Gliosis |
C00002355
|
D006212 | Hallucinations |
C00002355
|
D006261 | Headache |
C00002355
|
D006940 | Hyperemia |
C00002355
|
D006948 | Hyperkinesis |
C00002355
|
D006973 | Hypertension |
C00002355
|
D007022 | Hypotension |
C00002355
|
D007035 | Hypothermia |
C00002355
|
D007249 | Inflammation |
C00002355
|
D007859 | Learning Disorders |
C00002355
|
D053609 | Lethargy |
C00002355
|
D008569 | Memory Disorders |
C00002355
|
D001523 | Mental Disorders |
C00002355
|
D015877 | Miosis |
C00002355
|
D028361 | Mitochondrial Diseases |
C00002355
|
D009069 | Movement Disorders |
C00002355
|
D015878 | Mydriasis |
C00002355
|
D009207 | Myoclonus |
C00002355
|
D009325 | Nausea |
C00002355
|
D009336 | Necrosis |
C00002355
|
D009389 | Neovascularization, Pathologic |
C00002355
|
D009410 | Nerve Degeneration |
C00002355
|
D009421 | Nervous System Malformations |
C00002355
|
D019954 | Neurobehavioral Manifestations |
C00002355
|
D019636 | Neurodegenerative Diseases |
C00002355
|
D020258 | Neurotoxicity Syndromes |
C00002355
|
D009798 | Ocular Hypertension |
C00002355
|
D015814 | Ocular Hypotension |
C00002355
|
D010146 | Pain |
C00002355
|
D010554 | Personality Disorders |
C00002355
|
D011605 | Psychoses, Substance-Induced |
C00002355
|
D012598 | Sclerosis |
C00002355
|
D012640 | Seizures |
C00002355
|
D012798 | Sialorrhea |
C00002355
|
D012859 | Sjogren's Syndrome |
C00002355
|
D013226 | Status Epilepticus |
C00002355
|
D014202 | Tremor |
C00002355
|
D014549 | Urinary Incontinence |
C00002355
|
D014786 | Vision Disorders |
C00002355
|
D014987 | Xerostomia |
C00002355
|